Reckitt Benckiser Group (OTCMKTS:RBGLY) Upgraded by Morgan Stanley to “Overweight” Rating

Morgan Stanley upgraded shares of Reckitt Benckiser Group (OTCMKTS:RBGLYFree Report) from an equal weight rating to an overweight rating in a research report report published on Monday, Marketbeat reports.

A number of other research analysts also recently issued reports on the company. Zacks Research upgraded Reckitt Benckiser Group to a “hold” rating in a research note on Tuesday, March 3rd. Royal Bank Of Canada cut shares of Reckitt Benckiser Group from an “outperform” rating to a “sector perform” rating in a research note on Wednesday, January 14th. Citigroup began coverage on shares of Reckitt Benckiser Group in a report on Wednesday, January 14th. They set a “buy” rating on the stock. Jefferies Financial Group reissued a “hold” rating on shares of Reckitt Benckiser Group in a research note on Wednesday, January 7th. Finally, Barclays upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research report on Monday, December 1st. Two equities research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.

Read Our Latest Report on Reckitt Benckiser Group

Reckitt Benckiser Group Trading Up 3.1%

OTCMKTS:RBGLY opened at $14.59 on Monday. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.56 and a quick ratio of 0.37. The stock has a 50-day simple moving average of $16.56 and a two-hundred day simple moving average of $15.95. Reckitt Benckiser Group has a 52-week low of $12.49 and a 52-week high of $17.80.

About Reckitt Benckiser Group

(Get Free Report)

Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.

The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.

See Also

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.